Share on StockTwits
 

Shares of Pfizer (NYSE:PFE) was the target of unusually large options trading on Monday. Stock traders acquired 18,559 put options on the stock, Stock Ratings News reports. This is an increase of 150% compared to the average daily volume of 7,418 put options.

In other Pfizer news, EVP Frank Damelio sold 131,810 shares of Pfizer stock in a transaction dated Monday, January 13th. The shares were sold at an average price of $30.82, for a total transaction of $4,062,384.20. Following the transaction, the executive vice president now directly owns 356,451 shares in the company, valued at approximately $10,985,820. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link.

PFE has been the subject of a number of recent research reports. Analysts at TheStreet reiterated a “buy” rating on shares of Pfizer in a research note to investors on Tuesday, January 21st. Finally, analysts at Cowen and Company downgraded shares of Pfizer from an “outperform” rating to a “market perform” rating in a research note to investors on Friday, January 10th. They now have a $34.00 price target on the stock. Two research analysts have rated the stock with a sell rating, nine have issued a hold rating and ten have given a buy rating to the stock. Pfizer has a consensus rating of “Hold” and a consensus target price of $31.78.

Shares of Pfizer (NYSE:PFE) traded down 1.43% during mid-day trading on Monday, hitting $29.66. The stock had a trading volume of 33,094,512 shares. Pfizer has a 1-year low of $26.79 and a 1-year high of $32.50. The stock has a 50-day moving average of $30.73 and a 200-day moving average of $29.87. The company has a market cap of $192.2 billion and a P/E ratio of 8.31.

The company also recently declared a quarterly dividend, which is scheduled for Tuesday, March 4th. Shareholders of record on Friday, February 7th will be given a dividend of 0.26 per share. This represents a $1.04 dividend on an annualized basis and a yield of 3.51%. The ex-dividend date of this dividend is Wednesday, February 5th. This is a positive change from Pfizer’s previous quarterly dividend of $0.24.

Pfizer Inc (NYSE:PFE) is a research-based, global biopharmaceutical company.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.